Members of the previous forum can retrieve their temporary password here, (login and check your PM).

Reply to thread

Message

1. Frontiers isn't "fringe" at all. Yes it's newer than the "canon" (largely locked behind paywalls), but it's very mainstream now, with journals from a huge range of fields, from psychiatry to engineering to psychology - none of them fringe. It was founded by Henry Markram, who can hardly be called fringe haha. However, we chose Frontiers since the Imperial team (and myself, Ede Frecska, and others) have published on psychedelics there before. They are pretty open to this kind of work and a nice journal to work with....

Actually, Rick, Ede Frecska, and myself are currently accepting submissions for a special Frontiers Research Topic devoted to psychedelics (to be published as a free ebook next year). We already have a good number of high profile psychedelic researchers on board, but anyone can submit a paper (if any scientific Nexians are interested!):

[URL unfurl="true"]http://journal.frontiersin.org/researchtopic/5512/psychedelic-drug-research-in-the-21st-century[/URL]

Anyway, there's certainly nothing "fringe" or controversial about our article - it's mainly a mathematical model and simulation based on experimental (blood sampling) data. It's about as non-controversial as you can get really. The only potentially controversial or fringe element is introduced when one thinks about how the model might be applied in humans and for what purpose. But we only give a few ideas in the paper. The bulk of the paper is development of the mathematical model and analysis of the simulations - hardly fringe stuff!

2. Whatever your opinions on Strassman's "other" work of late, I think it unfair and somewhat disrespectful to call him a loon. Just remember who it was who had the balls and tenacity to execute that original DMT study in the 90s and how valuable it was, not only for DMT research, but for blazing the trail for much of the work on psychedelics that's followed since then. Strassman still advises on a very large number of psychedelic studies (including those of the Imperial team) and continues to be invaluable in this regard.

Ahoy! :d

<blockquote data-quote="laughingcat" data-source="post: 3793872" data-attributes="member: 10508">1. Frontiers isn&#039;t &quot;fringe&quot; at all. Yes it&#039;s newer than the &quot;canon&quot; (largely locked behind paywalls), but it&#039;s very mainstream now, with journals from a huge range of fields, from psychiatry to engineering to psychology - none of them fringe. It was founded by Henry Markram, who can hardly be called fringe haha. However, we chose Frontiers since the Imperial team (and myself, Ede Frecska, and others) have published on psychedelics there before. They are pretty open to this kind of work and a nice journal to work with....Actually, Rick, Ede Frecska, and myself are currently accepting submissions for a special Frontiers Research Topic devoted to psychedelics (to be published as a free ebook next year). We already have a good number of high profile psychedelic researchers on board, but anyone can submit a paper (if any scientific Nexians are interested!):[URL unfurl=&quot;true&quot;]http://journal.frontiersin.org/researchtopic/5512/psychedelic-drug-research-in-the-21st-century[/URL]Anyway, there&#039;s certainly nothing &quot;fringe&quot; or controversial about our article - it&#039;s mainly a mathematical model and simulation based on experimental (blood sampling) data. It&#039;s about as non-controversial as you can get really. The only potentially controversial or fringe element is introduced when one thinks about how the model might be applied in humans and for what purpose. But we only give a few ideas in the paper. The bulk of the paper is development of the mathematical model and analysis of the simulations - hardly fringe stuff!2. Whatever your opinions on Strassman&#039;s &quot;other&quot; work of late, I think it unfair and somewhat disrespectful to call him a loon. Just remember who it was who had the balls and tenacity to execute that original DMT study in the 90s and how valuable it was, not only for DMT research, but for blazing the trail for much of the work on psychedelics that&#039;s followed since then. Strassman still advises on a very large number of psychedelic studies (including those of the Imperial team) and continues to be invaluable in this regard.Ahoy! :d</blockquote>

[QUOTE="laughingcat, post: 3793872, member: 10508"] 1. Frontiers isn't "fringe" at all. Yes it's newer than the "canon" (largely locked behind paywalls), but it's very mainstream now, with journals from a huge range of fields, from psychiatry to engineering to psychology - none of them fringe. It was founded by Henry Markram, who can hardly be called fringe haha. However, we chose Frontiers since the Imperial team (and myself, Ede Frecska, and others) have published on psychedelics there before. They are pretty open to this kind of work and a nice journal to work with.... Actually, Rick, Ede Frecska, and myself are currently accepting submissions for a special Frontiers Research Topic devoted to psychedelics (to be published as a free ebook next year). We already have a good number of high profile psychedelic researchers on board, but anyone can submit a paper (if any scientific Nexians are interested!): [URL unfurl="true"]http://journal.frontiersin.org/researchtopic/5512/psychedelic-drug-research-in-the-21st-century[/URL] Anyway, there's certainly nothing "fringe" or controversial about our article - it's mainly a mathematical model and simulation based on experimental (blood sampling) data. It's about as non-controversial as you can get really. The only potentially controversial or fringe element is introduced when one thinks about how the model might be applied in humans and for what purpose. But we only give a few ideas in the paper. The bulk of the paper is development of the mathematical model and analysis of the simulations - hardly fringe stuff! 2. Whatever your opinions on Strassman's "other" work of late, I think it unfair and somewhat disrespectful to call him a loon. Just remember who it was who had the balls and tenacity to execute that original DMT study in the 90s and how valuable it was, not only for DMT research, but for blazing the trail for much of the work on psychedelics that's followed since then. Strassman still advises on a very large number of psychedelic studies (including those of the Imperial team) and continues to be invaluable in this regard. Ahoy! :d [/QUOTE]